Expanding into new markets places a spotlight on inefficient processes, highlighting the need for greater agility and major changes to regulatory systems and processes.
Read about the drivers and trends within these RIM Transformation Initiatives.
IMS Institute for Healthcare Informatics, Global Medicines Use in 2020, November 2015.
Elements of ISO IDMP-compliant SPOR data will be used in ICSR E2B(R3), the Falsified Medicines Directive (FMD), and European Clinical Trials Database (EudraCT).
Gens & Associates, Pursuing World Class RIM: Strategy, Measures and Priorities, November 2016.
Ibid.
The Veeva RIM Platform includes the following products: Veeva Registrations, Veeva Submissions, Veeva Submissions Archive, Veeva Submissions Publishing.
Major markets: United States, Canada, Japan, France, Germany, Spain, United Kingdom, Italy.
Growth markets: China, Brazil, Russia, India, Mexico, Turkey, Poland, Venezuela, Argentina, Indonesia, South africa, Thailand, Romania, Egypt, Ukraine, Pakistan, Vietnam.
